Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry

J Ethnopharmacol. 2013 Oct 7;149(3):810-5. doi: 10.1016/j.jep.2013.08.010. Epub 2013 Aug 14.

Abstract

Ethnopharmacological relevance: Diosbulbin B (DB) is the main constituent of furano-norditerpenes in Dioscorea bulbifera Linn., which is widely distributed in China and was usually used as a remedy for sore throat, struma and tumor. Owing to its potential antitumor activity, DB has been considered as a promising candidate for drug development.

Aim of the study: To study the pharmacokinetic properties and excretion of DB in rats by a sensitive UPLC-MS/MS method. Absolute bioavailability and gender-related pharmacokinetic properties, as well as excretion fractions of DB in urine and feces after oral and intravenous administrations would be addressed for the first time.

Materials and methods: Sprague-Dawley rats were administrated orally (32mg/kg) and intravenously (0.5mg/kg) of DB, respectively. The concentrations of DB in rat plasma were determined by a sensitive and well-validated LC-MS/MS method. Main pharmacokinetic parameters including area under the plasma concentration-time curve (AUC), elimination half time (t1/2), mean residence time (MRT), apparent volume of distribution (Vd) and clearance rate (CL) were estimated using a non-compartmental pharmacokinetics data analysis software. Urine and feces of rats were collected within 48h after oral administration (32mg/kg) and detected by UPLC-MS/MS and HPLC, respectively.

Results: The standard curves of DB in rat plasma and urine showed good linearity in the concentration range of 1.0-515ng/mL in the method, with acceptable selectivity, precisions, recoveries, and stability. The oral absolute bioavailability of DB in female rats was 2.0%, significantly higher than that of males (0.3%) (p<0.05). Female rats demonstrated longer t1/2 and MRT (p<0.01), bigger Vd and higher CL (p<0.05) than males after intravenous administration of DB. Bigger but no significant difference in excretion fractions of urine and feces in female rats were observed, comparing to those in males.

Conclusion: A simple and sensitive UPLC-MS/MS method was developed to determine the pharmacokinetic profiles of DB in rats, as well as the excretion in rat urine. Gender exerted a significant influence on the pharmacokinetics and bioavailability of DB in rats. Female rats showed significantly better absorption of DB than males after oral administration.

Keywords: Absolute bioavailability; Diosbulbin B; Excretion; Gender difference; Pharmacokinetics; UPLC–MS/MS.

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Calibration
  • Chromatography, High Pressure Liquid
  • Dioscorea / chemistry*
  • Drugs, Chinese Herbal / isolation & purification
  • Drugs, Chinese Herbal / pharmacokinetics*
  • Feces / chemistry
  • Female
  • Heterocyclic Compounds, 4 or More Rings / blood
  • Heterocyclic Compounds, 4 or More Rings / isolation & purification
  • Heterocyclic Compounds, 4 or More Rings / pharmacokinetics*
  • Heterocyclic Compounds, 4 or More Rings / urine
  • Injections, Intravenous
  • Male
  • Metabolic Clearance Rate
  • Rats
  • Rats, Sprague-Dawley
  • Reproducibility of Results
  • Sex Characteristics*
  • Tandem Mass Spectrometry

Substances

  • Drugs, Chinese Herbal
  • Heterocyclic Compounds, 4 or More Rings
  • diosbulbin B